Breast cancer treatment, particularly for new treatments in clinical trials, among them include:
Sentinel lymph node biopsy followed by surgery: the sentinel node is the first to receive drainage from the tumor. This procedure to remove a node. It injects a radioactive substance or dye near the tumor. Substance / dye flows through lymph channels and the first node to receive the substance to be removed. Later, the pathologist view network microscope for the presence of tumor cells. If not, is not required removal of other nodes. After the biopsy is necessary to remove the tumor. See picture 2. High-dose chemotherapy with stem cell transplantation: is giving large doses of chemotherapy and subsequent replacement of blood cells from stem cells destroyed by the patient or donor, suspended until the end of chemotherapy and then grafted into the patient. However, several studies have shown that this process does not get better results than standard chemotherapy treatments, plus high-dose chemotherapy can cause great damage, even death, so it was decided that the experiment is only testing the doctor. 3. Monoclonal antibodies as adjuvant therapy: treatment that uses antibodies made in the laboratory of one type of immune system cells. These antibodies have the ability to identify substances on cancer cells or normal substances in our body that encourages the growth of tumor cells. Antibodies attached to the substances and kill cancer cells. These antibodies can also be used in combination with chemotherapy. Trastuzumab is a monoclonal antibody that blocks the growth effects of the protein HER2, which transmits growth signals cacnerosas cells. 4. Tyrosine kinase inhibitors as adjuvant therapy: a drug that blocks the signals that tumor cells need to grow. These inhibitors can be combined with other drugs as adjuvant therapy. Lapatinib is an inhibitor that blocks the effects of HER2 and other proteins in cancer cells. It can be used in patients with HER2-positive breast cancer after failure of trastuzumab.
Sentinel lymph node biopsy followed by surgery: the sentinel node is the first to receive drainage from the tumor. This procedure to remove a node. It injects a radioactive substance or dye near the tumor. Substance / dye flows through lymph channels and the first node to receive the substance to be removed. Later, the pathologist view network microscope for the presence of tumor cells. If not, is not required removal of other nodes. After the biopsy is necessary to remove the tumor. See picture 2. High-dose chemotherapy with stem cell transplantation: is giving large doses of chemotherapy and subsequent replacement of blood cells from stem cells destroyed by the patient or donor, suspended until the end of chemotherapy and then grafted into the patient. However, several studies have shown that this process does not get better results than standard chemotherapy treatments, plus high-dose chemotherapy can cause great damage, even death, so it was decided that the experiment is only testing the doctor. 3. Monoclonal antibodies as adjuvant therapy: treatment that uses antibodies made in the laboratory of one type of immune system cells. These antibodies have the ability to identify substances on cancer cells or normal substances in our body that encourages the growth of tumor cells. Antibodies attached to the substances and kill cancer cells. These antibodies can also be used in combination with chemotherapy. Trastuzumab is a monoclonal antibody that blocks the growth effects of the protein HER2, which transmits growth signals cacnerosas cells. 4. Tyrosine kinase inhibitors as adjuvant therapy: a drug that blocks the signals that tumor cells need to grow. These inhibitors can be combined with other drugs as adjuvant therapy. Lapatinib is an inhibitor that blocks the effects of HER2 and other proteins in cancer cells. It can be used in patients with HER2-positive breast cancer after failure of trastuzumab.
Tidak ada komentar:
Posting Komentar